Form 8-K - Current report:
SEC Accession No. 0001372514-25-000053
Filing Date
2025-06-04
Accepted
2025-06-04 14:34:24
Documents
12
Period of Report
2025-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20250604.htm   iXBRL 8-K 37460
  Complete submission text file 0001372514-25-000053.txt   158883

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20250604.xsd EX-101.SCH 1800
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20250604_lab.xml EX-101.LAB 23451
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20250604_pre.xml EX-101.PRE 13593
14 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20250604_htm.xml XML 2914
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 251022773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)